Temozolomide Capsule
Product Images NDC 47335-930

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 47335-930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-temozolomide-label-100mg (Spl Temozolomide Label 100mg)

Each capsule of this medication contains 100mg of USP temozolomide and is intended for oral administration only. The package insert should be consulted to determine the appropriate dosage, which may require using different strengths of capsules. As a cytotoxic agent, the medication requires special handling and should be stored in light-resistant containers at a temperature range of 15°C to 30°C (59°F to 86°F). The medication is distributed by Sun Pharmaceutical Industries and manufactured by Sun Pharmaceutical Industries Ltd. Due to errors, the text includes some typos and garbled characters.*

FDA Label Image

Spl-temozolomide-label-140mg (Spl Temozolomide Label 140mg)

Each capsule of the medication contains 140 mg temozolomide, a cytotoxic agent, used for oral administration. The package insert of Temozolomide Capsules provides information on the recommended dosage according to the strength of the capsule to establish a daily regimen. The medication should be stored in a tight, light-resistant container or the original bottle at room temperature between 15°C to 30°C. Sun Pharmaceutical Industries, Inc. distributes the medication, and Sun Pharmaceutical Ind. Ltd. manufactures the drug.*

FDA Label Image

Spl-temozolomide-label-180mg (Spl Temozolomide Label 180mg)

Each capsule contains 180mg of Temozolomide for daily regimen use. Please reference the package insert for dosage recommendations based on capsule strength. Caution: this is a cytotoxic agent that requires proper handling and should be dispensed in a light-resistant container. Store at 25°C (77°F) but expeditions are permitted. The drug is manufactured by Sun Pharma and distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ 08512.*

FDA Label Image

Spl-temozolomide-label-20mg (Spl Temozolomide Label 20mg)

Each capsule of the medicine contains 20 mg of temozolomide, USP. The recommended dosage is available on the package insert. The medicine is manufactured by Sun Pharmaceutical Ind. Ltd. and should be stored in light-resistant containers at 25°C (77°F). The medicine should be dispensed carefully as per the instructions. The medicine is available in the original bottle and retail stores. The excursions allowed are 15° to 30°C (59° to 86°F). The NDC number for the medicine is 47335-891-80.*

FDA Label Image

Spl-temozolomide-label-250mg (Spl Temozolomide Label 250mg)

Each capsule contains 250 mg of Temazolomide, a cytotoxic agent, for oral administration. The package insert provides recommendations for establishing a daily regimen through the use of varying capsule strengths. Dispense in tight, light-resistant containers as defined in USP/NF or retain the original bottle. The manufacturer recommends storing at 25°C (77°F), with excursions allowed between 10-15° to 30°C (59° to 86° F). The product is distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ, and manufactured by Sun Pharmaceutical Ind. Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India. The NDC number for this medication is 47335-893-80.*

FDA Label Image

Spl-temozolomide-label-5mg (Spl Temozolomide Label 5mg)

Each capsule contains 5 mg of temozolomide, USP, a cytotoxic agent used for oral administration. The recommended daily regimen may vary based on individual strength requirements. Please read the accompanying directions carefully and store the capsules in a tight, light-resistant container at 25°C (77°F) with permitted excursions to 10-15°C (50-59°F) and 30-30°C (68-86°F). The capsules are distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Sun Pharmaceutical Ind. Ltd. in Gujarat, India. The batch number is not available.*

FDA Label Image

Spl-temozolomide-s1-100mg (Spl Temozolomide S1 100mg)

NDC 47335-892-75 is a prescription-only medication used for oral administration. It consists of 20 unit-dose capsules, each containing 100mg temozolomide, which is a cytotoxic agent. It is manufactured by Sun Pharmaceutical Industries, Inc. and distributed in the US by Sun Pharmaceutical Industries, Inc., Cranbury, NJ. The capsules should not be opened and should be handled carefully to avoid inhalation or skin contact. They should be stored at room temperature (25°C or 77°F). The package is child-resistant and will be useless if the individual unit is open or torn. Special dispensing information is included with the package, and the pharmacist should review it carefully before dispensing. The usual dosage should be followed according to the package insert.*

FDA Label Image

Spl-temozolomide-s1-140mg (Spl Temozolomide S1 140mg)

Temozolomide Capsules is a cytotoxic drug for oral administration, to be dispensed with special care by pharmacists. Manufactured by Sun Pharmaceutical Industries in Gujarat, India, the package contains 20 (4X 5) unit-dose capsules. Each capsule carries 140 mg temozolomide, USP. The packaging bears special dispensing information, and the accompanying guidelines should be read carefully. To maintain potency, the capsules should be stored in line with USP Controlled Room Temperature between 15°C and 30°C (59°F to 86°F). The package is child-resistant, and precautions should be taken to avoid accidental opening or damage of the capsules during use.*

FDA Label Image

Spl-temozolomide-s1-180mg (Spl Temozolomide S1 180mg)

This is a description of Temozolomide Capsules containing 180mg of the drug per capsule, in a package of 20 capsules (4x5 unit-dose). The drug is a cytotoxic agent and requires special handling by pharmacists. It is manufactured in India by Sun Pharmaceutical Industries and distributed in the US by the same company's US branch. The capsules should not be opened or damaged, and precautions should be taken in handling them. The capsules should be stored at 25°C (77°F), and the package is child-resistant. The recommended dosage is to consult the package insert.*

FDA Label Image

Spl-temozolomide-s1-20mg (Spl Temozolomide S1 20mg)

This is a product description of Temozolomide Capsules, containing 20 mg of the active ingredient, for oral administration. It is a cytotoxic agent that needs special handling. It comes in a package containing 20 unit-dose capsules with special dispensing information included. The capsule should not be opened as it may cause inhalation or skin contact. It should be stored at a controlled room temperature of 25°C (77°F) with an excursion to 16°C to 30°C (59° to 86°F). The unit-dose package is child-resistant and not available if the individual blister unit is opened or torn. The manufacturer is Sun Pharmaceutical Industries, with its address in Halol-Baroda Highway, Halol, Gujarat, India.*

FDA Label Image

Spl-temozolomide-s1-250mg (Spl Temozolomide S1 250mg)

The text is a description of Temozolomide Capsules, a cytotoxic agent for oral administration. The medication comes in a 20 (4X5) Unit-Dose Capsules package, each capsule contains 250 mg temozolomide, and should not be opened as it could be harmful. The medication must be handled with care, and the pharmacist should review the special dispensing instructions carefully before giving it to the patient. If accidentally opened or damaged, the contents must be dealt with cautiously to avoid inhalation or contact with the skin or mucous membranes. The unit-dose package is child-resistant, and the medication should be stored at room temperature. Please read the accompanying instructions carefully for recommended dosages.*

FDA Label Image

Spl-temozolomide-s1-5mg (Spl Temozolomide S1 5mg)

FDA Label Image

Spl-temozolomide-sb-100mg (Spl Temozolomide Sb 100mg)

This is a description of medication called Temozolomide Capsules which contains 100mg of temazolomide. The recommended dosage information can be found inside the package. The capsules should not be opened and if accidentally opened or damaged, precautions should be taken. The medication is distributed by Sun Pharmaceutical Industries Inc. and manufactured by Sun Pharmaceutical Ind. Ltd in India. The full NDC code is 47335-892-80. This medication is a cytotoxic agent and requires special handling by the pharmacist. The package contains five capsules.*

FDA Label Image

Spl-temozolomide-sb-140mg (Spl Temozolomide Sb 140mg)

This document seems to be product information for Temozolomide Capsules, a medication containing 140mg of Tamozomide that is used as a cytotoxic agent. The recommended dosage and handling instructions are included. The capsules should not be opened or damaged and should be stored in a controlled room temperature. The manufacturer is Sun Pharmaceutical Industries, and the capsules are available in varying strengths. Special dispensing instructions are included for pharmacists.*

FDA Label Image

Spl-temozolomide-sb-180mg (Spl Temozolomide Sb 180mg)

This is a description for Temozolomide Capsules, a cytotoxic agent, used for oral administration. The usual dosage should be determined by following the recommendations mentioned in the package insert. The capsules should not be opened, and if accidentally opened, precautions should be taken to avoid inhalation or contact with the skin or mucous membranes. The medicine must be stored at controlled room temperature, and dispensed in light-resistant containers. Manufacturer and distributor details are provided. The text contains several errors making the text harder to read.*

FDA Label Image

Spl-temozolomide-sb-20mg (Spl Temozolomide Sb 20mg)

This product is a medication contained in capsules, each with 20 mg of temozolomide, a cytotoxic agent. The recommended dosage can be found inside the package insert, and particular caution should be taken when handling the capsules. They should not be opened, and if accidentally opened, their content should not come in contact with the skin or mucous membranes. The capsules should be stored within USP controlled room temperature provisions to ensure their integrity. The medication is distributed by Sun Pharmaceutical Industries, Inc. and should be dispensed in the original container. There is special dispensing information related to the medication that needs to be reviewed carefully by the pharmacist.*

FDA Label Image

Spl-temozolomide-sb-250mg (Spl Temozolomide Sb 250mg)

This is a label for a medication called Temozolomide Capsules. It contains information on the dosage, handling, and storage of the product, as well as the manufacturer and distributor details. This medicine is a cytotoxic agent, and therefore requires special handling. The capsules should not be opened, and rigorous precautions should be taken with the contents to avoid inhalation or contact with the skin or mucous membranes. The label also includes the usual dosage, which should be determind by reading the accompanying instructions carefully. *

FDA Label Image

Spl-temozolomide-sb-5mg (Spl Temozolomide Sb 5mg)

This is a description of a medication called Temozolomide Capsules. Each capsule contains 5mg of temozolomide USP. Its usual dosage will vary based on the strength of the medication, and it should not be opened. It's a cytotoxic agent with special handling instructions for rigorous precaution when handling or administering. This medication is distributed by Sun Pharmaceutical Industries and manufactured by Sun Pharmaceutical Ind. Ltd, and comes in a bottle with 5 capsules.*

FDA Label Image

Spl-temozolomide-structure (Spl Temozolomide Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.